• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
TAN Xiaoyun,CHEN Zhen.Research progress on key proteins in vascular cognitive impairment[J].Journal Of Pharmaceutical Research,2022,41(10):678-682[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2153times   Download 2289次 QR Code for this article
Scan with your phone!
血管性认知障碍的关键蛋白研究进展
谭晓云,陈真
Font:Larger+|Default|Smaller-
(中国药科大学药学院,江苏 南京 211198)
摘要:
血管性认知障碍是指由各种脑血管疾病引起的认知损害,范围包括从轻度认知损害到血管性痴呆。它通常会影响大脑的高级功能,特别是在执行功能和记忆方面。近年来随着血管性认知障碍发病率的逐步上升,针对血管性认知障碍发病机制的通路研究也在不断深入。本文对血管性认知障碍的关键靶蛋白进行综述,为血管性认知障碍的治疗和用药提供参考。
关键词:  血管性认知障碍  关键蛋白  研究进展
DOI:10.13506/j.cnki.jpr.2022.10.010
基金项目:
Research progress on key proteins in vascular cognitive impairment
TAN Xiaoyun,CHEN Zhen
(School of Pharmacy,China Pharmaceutical University,Nanjing 211198,China)
Abstract:
Vascular cognitive impairment refers to cognitive impairment caused by various cerebrovascular diseases, ranging from mild cognitive impairment to vascular dementia. VCI usually affects the advanced functions of the brain, especially in the areas of executive function and memory. With the gradual increase in the incidence of vascular cognitive impairment, in recent years, research on the pathogenesis of vascular cognitive impairment is also deepening. This article reviewed the key target proteins of vascular cognitive impairment, and provides references for the treatment and medication of vascular cognitive impairment.
Key words:  Vascular cognitive impairment  Key proteins  Research progress
Today's Visits:485    Total Visits:2383197
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.